csirt@kutim:~/threat-intel/cve/CVE-2023-52668

Katalog CVE

CVSS 5.5 · Medium EPSS 0,18%

Kerentanan Improper Locking pada linux kernel. Skor CVSS 3.1 5.5 (Medium) menurut NVD.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: btrfs: zoned: fix lock ordering in btrfs_zone_activate() The btrfs CI reported a lockdep warning as follows by running generic generic/129. WARNING: possible circular locking dependency detected 6.7.0-rc5+ #1 Not tainted ------------------------------------------------------ kworker/u5:5/793427 is trying to acquire lock: ffff88813256d028 (&cache->lock){+.+.}-{2:2}, at: btrfs_zone_finish_one_bg+0x5e/0x130 but task is already holding lock: ffff88810a23a318 (&fs_info->zone_active_bgs_lock){+.+.}-{2:2}, at: btrfs_zone_finish_one_bg+0x34/0x130 which lock already depends on the new lock. the existing dependency chain (in reverse order) is: -> #1 (&fs_info->zone_active_bgs_lock){+.+.}-{2:2}: ... -> #0 (&cache->lock){+.+.}-{2:2}: ... This is because we take fs_info->zone_active_bgs_lock after a block_group's lock in btrfs_zone_activate() while doing the opposite in other places. Fix the issue by expanding the fs_info->zone_active_bgs_lock's critical section and taking it before a block_group's lock.

Rincian

Terbit di NVD
17 Mei 2024
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
5.5 (Medium), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-667: Improper Locking
EPSS (30 hari)
0,18% peluang dieksploitasi; lebih tinggi dari 6,5% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 6.6 hingga sebelum 6.6.15
linux linux kernel Versi 6.7 hingga sebelum 6.7.3
linux linux kernel Versi 6.8 rc1

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.